NYSEMKT: NRXS
Neuraxis Inc Stock Ownership - Who owns Neuraxis?

Insider buying vs selling

Have Neuraxis Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NRXS insiders and whales buy or sell their stock.

NRXS Shareholders

What type of owners hold Neuraxis Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Christopher Robin Brown10.99%792,837$1.27MInsider
Brian Hannasch10.50%757,901$1.21MInsider
Masimo Corp7.37%531,548$850.48kInsider
Gary Merril Peterson7.18%518,120$828.99kInsider
Bank Of Montreal1.93%139,017$222.43kInstitution
Parsons Capital Management Inc1.62%116,726$186.76kInstitution
Citadel Advisors LLC0.65%47,094$75.35kInstitution
Vanguard Group Inc0.39%27,981$44.77kInstitution
Brian Allen Carrico0.38%27,118$43.39kInsider
Stifel Financial Corp0.36%25,710$41.14kInstitution

1 of 3

NRXS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRXS5.54%36.89%
BLRX0.09%0.00%
IMNN2.91%63.41%Net Buying
MRKR3.14%96.86%Net Buying
BRTX0.27%99.73%Net Selling

Neuraxis Stock Ownership FAQ

Who owns Neuraxis?

Neuraxis (NYSEMKT: NRXS) is owned by 5.54% institutional shareholders, 36.89% Neuraxis insiders, and 57.57% retail investors. Christopher Robin Brown is the largest individual Neuraxis shareholder, owning 792,837.00 shares representing 10.99% of the company. Christopher Robin Brown's Neuraxis shares are currently valued at $1.42M.

If you're new to stock investing, here's how to buy Neuraxis stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.